The American Journal of Medicine
Volume 116, Issue 3 , Pages 151-157 , 1 February 2004

Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking

  • Dorothy K Hatsukami, PhD

      Affiliations

    • Department of Psychiatry (DKH, MK), University of Minnesota at Twin Cities, Minneapolis, Minnesota, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Dorothy K. Hatsukami, PhD, University of Minnesota, Tobacco Use Research Center, 2701 University Avenue, Suite 201, Minneapolis, Minnesota 55414, USA
    • ,
  • Stephen Rennard, MD

      Affiliations

    • University of Nebraska Medical Center (SR), Omaha, Nebraska, USA
    • ,
  • Manoj K Patel, PharmD

      Affiliations

    • GlaxoSmithKline (MKP, MK, GD, BDJ), Research Triangle Park, North Carolina, USA
    • ,
  • Michael Kotlyar, PharmD

      Affiliations

    • Department of Psychiatry (DKH, MK), University of Minnesota at Twin Cities, Minneapolis, Minnesota, USA
    • Department of Experimental and Clinical Pharmacology, College of Pharmacy (MK), University of Minnesota at Twin Cities, Minneapolis, Minnesota, USA
    • GlaxoSmithKline (MKP, MK, GD, BDJ), Research Triangle Park, North Carolina, USA
    • ,
  • Robert Malcolm, MD

      Affiliations

    • Institute of Psychiatry (RM), Medical University of South Carolina, Charleston, South Carolina, USA
    • ,
  • Mitchell A Nides, PhD

      Affiliations

    • Los Angeles Clinical Trials (MAN), Los Angeles, California, USA
    • ,
  • Greg Dozier, MPH

      Affiliations

    • GlaxoSmithKline (MKP, MK, GD, BDJ), Research Triangle Park, North Carolina, USA
    • ,
  • Matthew P Bars, MS

      Affiliations

    • Smoking Consultation Service (MPB), Fort Lee, New Jersey, USA
    • ,
  • Brenda D Jamerson, PharmD

      Affiliations

    • GlaxoSmithKline (MKP, MK, GD, BDJ), Research Triangle Park, North Carolina, USA
    • Campbell University Department of Pharmaceutical Sciences, Clinical Research (BDJ), Durham, North Carolina, USA

Received 26 June 2002 ,Accepted 25 July 2003.

References 

  1. Etter JF, Perneger TV, Ronchi A. Distributions of smokers by stage (international comparison and association with smoking prevalence). Prev Med. 1997;26:580–585
  2. CDC . Cigarette smoking among adults—United States, 2001. MMWR Morb Mortal Wkly Rep. 2003;52:953–956
  3. Fagerstrom KO, Tejding R, Westin A, Lunell E. Aiding reduction of smoking with nicotine replacement medications (hope for the recalcitrant smoker?). Tob Control. 1997;6:311–316
  4. Stratton K, Shetty P, Wallace R, Bondurant S. Clearing the Smoke (Assessing the Science Base for Tobacco Harm Reduction). Washington, DC: Institute of Medicine National Academy Press; 2001;
  5. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect. 1999;107(suppl 2):349–355
  6. Henningfield JE, Stitzer ML, Griffiths RR. Expired air carbon monoxide accumulation and elimination as a function of number of cigarettes smoked. Addict Behav. 1980;5:265–372
  7. Jacob P, Yu L, Shulgin AT, Benowitz NL. Minor tobacco alkaloids as biomarkers for tobacco use (comparison of users of cigarettes, smokeless tobacco, cigars, and pipes). Am J Public Health. 1999;89:731–736
  8. Hughes JR. Reduced smoking (an introduction and review of the evidence). Addiction. 2000;95(suppl 1):S3–S7
  9. Fiore M, Bailey WC, Cohen SJ, et al.  Treating Tobacco Use and Dependence Clinical Practice Guideline. Washington, DC: U.S. Department of Health and Human Services Public Health Service; 2000;
  10. Bolliger CT, Zellweger JP, Danielsson T, et al.  Smoking reduction with oral nicotine inhalers (double blind, randomised clinical trial of efficacy and safety). BMJ. 2000;321:329–333
  11. Etter JF, Laszlo E, Zellweger JP, et al.  Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit (a randomized trial). J Clin Psychopharmacol. 2002;22:487–495
  12. Hill D, Weiss DJ, Walker DL, Jolley D. Long-term evaluation of controlled smoking as a treatment outcome. Br J Addict. 1988;83:203–207
  13. Glasgow RE, Klesges RC, Klesges LM, et al.  Long-term effects of a controlled smoking program (a 2 1/2 year follow-up). Behav Ther. 1985;16:303–307
  14. Rennard SI, Daughton D, Fujita J, et al.  Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers. Eur Respir J. 1990;3:752–759
  15. Hurt RD, Croghan GA, Wolter TD, et al.  Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob Res. 2000;2:327–336
  16. Faucette SR, Hawke RL, Lecluyse EL, et al.  Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos. 2000;28:1222–1230
  17. Yamazaki H, Inoue K, Hashimoto M, Shimada T. Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol. 1999;73:65–70
  18. Pulera N, Petruzzelli S, Celi A, et al.  Presence and persistence of serum anti-benzo(a)pyrene diolepoxide-DNA adduct antibodies in smokers (effects of smoking reduction and cessation). Int J Cancer. 1997;70:145–149
  19. Szarewski A, Jarvis MJ, Sasieni P, et al.  Effect of smoking cessation on cervical lesion size. Lancet. 1996;347:941–943
  20. Buist AS, Sexton GJ, Nagy JM, Ross BB. The effect of smoking cessation and modification on lung function. Am Rev Respir Dis. 1976;114:115–122
  21. Lange P, Groth S, Nyboe GJ, et al.  Effects of smoking and changes in smoking habits on the decline of FEV1. Eur Respir J. 1989;2:811–816
  22. Eliasson B, Hjalmarson A, Kruse E, et al.  Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res. 2001;3:249–255

☆ This study was supported by GlaxoSmithKline, Research Triangle Park, North Carolina. The sponsor was responsible for finalizing the design of the study and oversight of the research project, had primary responsibility for conducting the data analyses, and reviewed the final paper.

PII: S0002-9343(03)00655-7

doi: 10.1016/j.amjmed.2003.07.018

The American Journal of Medicine
Volume 116, Issue 3 , Pages 151-157 , 1 February 2004

Article Tools

* Image Usage & Resolution